Correlation of Leukopenia with Vitamin D Levels in Ovarian Cancer Patients Undergoing Platinum-Taxane-Based Chemotherapy
DOI:
https://doi.org/10.25077/aoj.9.2.251-258.2025Keywords:
Ovarian Cancer, Chemotherapy, Platinum-Taxane, Leukopenia, Vitamin DAbstract
Introduction: Ovarian cancer is a significant cause of death in women. One of the management of advanced ovarian cancer patients is chemotherapy. The effects of administering Platinum-Taxane-Based chemotherapy to ovarian cancer patients show side effects of myelosuppression, one of which is leukopenia.
Methods: This type of study is a correlation analytical study with a cross-sectional design from October 2023 to May 2024 at Dr. M. Djamil Central General Hospital Padang. The patients included were ovarian cancer patients who underwent Platinum-Taxane-Based chemotherapy with laboratory results of leukopenia.
Results: From 70 patients, it was found that 37 patients (52.9%) had grade I leukopenia, 27 patients (38.6%) had grade II, and 6 patients (8.6%) had grade III. Based on the results obtained, in grade I leukopenia, the average vitamin D value is 13.162 ng/mL, grade II has an average vitamin D value of 11.851 ng/mL, grade III has an average vitamin D value of 14.333 ng/mL. The study results showed a relationship between leukopenia and vitamin D levels p = 0.034 (p < 0.05).
Conclusion: There was a relationship between leukopenia and vitamin D levels in ovarian cancer patients undergoing Platinum-Taxane-Based Chemotherapy at Dr. M. Djamil Central General Hospital Padang.
References
1. Taruna Arora; Sanjana Mullangi; Manidhar Reddy Lekkala. Ovarian Cancer [Internet]. StatPearls Publishing; 2022 Jan.; 2022. Available from: https://www.ncbi.nlm.nih.gov/books/NBK567760/#_NBK567760_pubdet_
2. Cancer Facts & Figures 2022. https://www.cancer.org/cancer/ovarian-cancer/about/key-statistics.html. 2022.
3. Chang LC, Huang CF, Lai MS, Shen LJ, Wu FLL, Cheng WF. Prognostic factors in epithelial ovarian cancer: A population-based study. PLoS One. 2018 Mar, doi: https://doi.org/10.1371/journal.pone.0194993
4. Winarto H, Wijaya A, Kunci K, Penelitian A. Gambaran Mielosupresi pada Pasien Kanker Ovarium yang Menerima Kemoterapi Carboplatin-Paclitaxel di RSUPN Cipto Mangunkusumo Tahun 2018.
5. Charles A, Dewayani BM, Sahiratmadja E, Winarno GNA, Susanto H. Paclitaxel-carboplatin chemotherapy-induced hematologic toxicities among epithelial ovarian cancer patients. Universa Medicina. 2016 Nov 30;35(3):165.
6. Medrano M, Carrillo-Cruz E, Montero I, Perez-Simon JA. Vitamin D: Effect on haematopoiesis and immune system and clinical applications. Vol. 19, International Journal of Molecular Sciences. MDPI AG; 2018.
7. Momenimovahed Z, Tiznobaik A, Taheri S, Salehiniya H. Ovarian cancer in the world: Epidemiology and risk factors. Vol. 11, International Journal of Women’s Health. Dove Medical Press Ltd; 2019. p. 287–99.
8. Ali AT, Al-Ani O, Al-Ani F. Epidemiology and risk factors for ovarian cancer. Vol. 22, Przeglad Menopauzalny. Termedia Publishing House Ltd.; 2023. p. 93–104.
9. Iversen L, Fielding S, Lidegaard Ø, Mørch LS, Skovlund CW, Hannaford PC. Association between contemporary hormonal contraception and ovarian cancer in women of reproductive age in Denmark: Prospective, nationwide cohort study. BMJ (Online). 2018;362.
10. Gaona-Luviano P, Adriana L, Medina-Gaona, Magaña-Pérez K. Epidemiology of ovarian cancer. Vol. 9, Chinese Clinical Oncology. AME Publishing Company; 2020.
11. Akin JM, Waddell JA, Solimando DA. Paclitaxel and carboplatin (TC) regimen for ovarian cancer. Vol. 49, Hospital Pharmacy. Facts and Comparisons; 2014. p. 425–31.
12. Keywanloo M, Ahmadi-Hamedani M, Javan JA, Zabol RF. Effects of Parenteral Vitamin D3 Supplementation on Hematological Parameters of Healthy Holstein Bulls. Arch Razi Inst. 2021 Nov 1;76(5):1155–63.
13. Alharbi A. A potential role of vitamin D on platelet leukocyte aggregation and pathological events in sepsis: An updated review. Vol. 14, Journal of Inflammation Research. Dove Medical Press Ltd; 2021. p. 3651–64.
14. Dovnik A, Dovnik NF. Vitamin D and ovarian cancer: Systematic review of the literature with a focus on molecular mechanisms. Vol. 9, Cells. Multidisciplinary Digital Publishing Institute (MDPI); 2020.
15. Parazzini F, Esposito G, Tozzi L, Noli S, Bianchi S. Epidemiology of endometriosis and its comorbidities. European Journal Obstetrics & Gynecology Reproductive Biology. 2016; 209: 3-7. DOI:10.1016/j.ejogrb.2016.04.021
16. Lee HJ, Park YM, Jee BC, Kim YB, Suh CS. Various anatomic locations of surgically proven endometriosis : A single-center experience. Obstetrics & Gynecology Science. 2015; 58: 53-8. DOI:10.5468/ogs.2015.58.1.53
17. Anastasilakis AD, Polyzos SA, Vorkas PA, Gkiomisi A, Yavropoulou MP, et.al. Lipid Profile after Pharmacologic Discontinuation and Restoration of Menstruation in Women with Endometriosis: A 12-Month Observational Prospective Study. J Clin Med. 2023 Aug 21;12(16):5430. DOI:10.3390/jcm12165430
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Puja Agung Antonius, Firdawati Firdawati, Syamel Muhammad, Hudila Rifa Karmia, Caesar Muhammad Wijaya

This work is licensed under a Creative Commons Attribution 4.0 International License.





